Related Experiment Video
Updated: May 11, 2025

Meal Duration as a Measure of Orofacial Nociceptive Responses in Rodents
Published on: January 10, 2014
Xerostomia correlates with pain sensitivity in burning mouth syndrome patients
Hongsen Zhao1, Shujun Ran2, Wenqian Huo3
1Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou City, 450052, China. zhaohongsen205@163.com.
Abstract:
Patients with burning mouth syndrome (BMS) often exhibit abnormal somatosensory function, and xerostomia is a common accompanying symptom. This study aimed to explore whether xerostomia is associated with pain sensitivity in patients with BMS. A total of 82 female patients with BMS were enrolled, including 55 with xerostomia. The pressure pain threshold (PPT) on the tongue was measured via a digital pressure algometer. Pain sensitivity was assessed via the Pain Sensitivity Questionnaire (PSQ). Whole saliva flow rates were measured. The severity of xerostomia was evaluated via the Summated Xerostomia Inventory (SXI). Descriptive statistics were performed, along with chi-square tests, Pearson correlation analyses, and multiple linear regression analyses. There were no significant differences in the PPT or stimulated saliva flow rates between BMS patients with and without xerostomia (112 ± 53 vs. 129 ± 57, p = 0.5837; 1.55 ± 0.73 vs. 1.64 ± 0.62, p = 0.5837, respectively). BMS patients with xerostomia had significantly higher PSQ-minor scores (4.55 ± 1.36 vs. 3.93 ± 1.11, p = 0.0432 < 0.05). PSQ-minor scores were correlated with the duration of xerostomia (β = 0.399, p = 0.003) but not with the severity of xerostomia. Xerostomia had different effects on the two pain sensitivity dimensions in patients with BMS: there was no significant change in the experimentally obtained pain threshold, while the self-assessed suprathreshold pain intensity increased.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Thermosensation
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Pain

